Operating Lease, Right-of-Use Asset of Vera Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Vera Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
Vera Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2,036,000, a 48% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vera Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$2,036,000	-$1,885,000	-48%	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$2,471,000	+$542,000	+28%	30 Jun 2025	10-Q	05 Aug 2025	2025	Q2
Q1 2025	$2,915,000	+$483,000	+20%	31 Mar 2025	10-Q	07 May 2025	2025	Q1
Q4 2024	$3,372,000	+$423,000	+14%	31 Dec 2024	10-Q	05 Nov 2025	2025	Q3
Q3 2024	$3,921,000	+$440,000	+13%	30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q2 2024	$1,929,000	-$2,101,000	-52%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	$2,432,000	-$2,162,000	-47%	31 Mar 2024	10-Q	10 May 2024	2024	Q1
Q4 2023	$2,949,000	-$2,224,000	-43%	31 Dec 2023	10-K	28 Feb 2025	2024	FY
Q3 2023	$3,481,000	-$2,287,000	-40%	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$4,030,000	-$1,694,000	-30%	30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$4,594,000	-$1,681,000	-27%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$5,173,000	+$5,173,000		31 Dec 2022	10-K	27 Mar 2024	2023	FY
Q3 2022	$5,768,000			30 Sep 2022	10-Q	09 Nov 2022	2022	Q3
Q2 2022	$5,724,000			30 Jun 2022	10-Q	10 Aug 2022	2022	Q2
Q1 2022	$6,275,000			31 Mar 2022	10-Q	16 May 2022	2022	Q1
Q4 2021	$0			31 Dec 2021	10-K	28 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.